CD69 and Alzheimer disease: Therefore, in order to evaluate the direct effect of the AD treatment effect of CDE on the activity of T cells and keratinocytes, the expression levels of CD69 and CD25 were evaluated in Jurkat T cells stimulated with CD3/28.